Authors:
Zehbe, I
Tachezy, R
Mytilineos, J
Voglino, G
Mikyskova, I
Delius, H
Marongiu, A
Gissmann, L
Wilander, E
Tommasino, M
Citation: I. Zehbe et al., Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes, INT J CANC, 94(5), 2001, pp. 711-716
Authors:
Zehbe, I
Voglino, G
Wilander, E
Delius, H
Marongiu, A
Edler, L
Klimek, F
Andersson, S
Tommasino, M
Citation: I. Zehbe et al., p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypesare risk factors for cervical cancer development, CANCER RES, 61(2), 2001, pp. 608-611
Authors:
Zehbe, I
Ratsch, A
Alunni-Fabbroni, M
Burzlaff, A
Bakos, E
Durst, M
Wilander, E
Tommasino, M
Citation: I. Zehbe et al., Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions, ONCOGENE, 18(13), 1999, pp. 2201-2211
Citation: I. Zehbe, Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms (vol 352, pg 1998, 1998), LANCET, 353(9165), 1999, pp. 1714-1714